Auris Medical registers $35 million of its stock for a public offering

Bookrunner Leerink Partners and lead managers JMP, Needham will assist

By Devika Patel

Knoxville, Tenn., April 22 – Auris Medical Holding AG will price a public offering of common stock with a 30-day greenshoe, according to a Form F-1 filed Wednesday with the Securities and Exchange Commission. The company has registered up to $35 million of stock.

Leerink Partners is the bookrunning manager. JMP Securities and Needham & Co. are the lead managers.

Proceeds will be used for research and development, working capital and other corporate purposes.

The biopharmaceutical company is based in Zug, Switzerland.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.